Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Noordhuis

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Analytical Biochemistry|October 10, 1995
Quantification of 5-fluorouracil incorporation into RNA of human and murine tumors as measured with a sensitive gas chromatography-mass spectrometry assayG J Peters, P Noordhuis, A Komissarov, et al.
Blood|February 25, 1999
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemiaM G Rots, R Pieters, G J Peters, et al.
Leukemia|February 24, 2001
mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR methodM G Rots, J C Willey, G Jansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenaseC H Smorenburg, G J Peters, C J van Groeningen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and clinical parametersR L Poorter, G J Peters, P J Bakker, et al.
The Journal of Biological Chemistry|November 7, 1998
A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistanceG Jansen, R Mauritz, S Drori, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2001
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemiaM G Rots, R Pieters, G Jansen, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenograftsA M Bergman, C M Kuiper, P Noordhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell linesB van Triest, H M Pinedo, Y van Hensbergen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumorsC J van Groeningen, G J Peters, J H Schornagel, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Analytical Biochemistry|October 10, 1995
Quantification of 5-fluorouracil incorporation into RNA of human and murine tumors as measured with a sensitive gas chromatography-mass spectrometry assayG J Peters, P Noordhuis, A Komissarov, et al.
Blood|February 25, 1999
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemiaM G Rots, R Pieters, G J Peters, et al.
Leukemia|February 24, 2001
mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR methodM G Rots, J C Willey, G Jansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenaseC H Smorenburg, G J Peters, C J van Groeningen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: relationship between plasma concentrations and clinical parametersR L Poorter, G J Peters, P J Bakker, et al.
The Journal of Biological Chemistry|November 7, 1998
A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistanceG Jansen, R Mauritz, S Drori, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2001
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemiaM G Rots, R Pieters, G Jansen, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 2, 2004
Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenograftsA M Bergman, C M Kuiper, P Noordhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell linesB van Triest, H M Pinedo, Y van Hensbergen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumorsC J van Groeningen, G J Peters, J H Schornagel, et al.
Pageof 5